In 1997, Karen Jargowsky was a high school senior who brought a full heart to her battle with acute mylogenous leukemia. During her treatment at UVA Children’s Hospital in Charlottesville, Karen gained the love and respect of dozens of caregivers, and when her cancer went into remission, Karen enrolled at UVA. The disease returned and claimed her life the following spring, prompting UVA to create the Karen Jargowsky Professorship in her memory.
Administered through the Community Foundation, the fund supports the work of the UVA Pediatric Hematology/Oncology Division at UVA Children’s Hospital. “Our goal is that no child or young adult has to leave the Commonwealth to receive the best innovative treatments for pediatric cancers or blood diseases,” says Kimberly Dunsmore, MD, Karen Jargowsky Professor and Chief of Pediatric Hematology/Oncology. With the support of the fund, the division has established an excellent pediatric hematology/oncology service and has become a leader in clinical research of pediatric blood cancers. A new Pediatric Stem Cell Transplant Program will provide clinical trials with CAR-T-cell immunotherapy, which has been shown to effectively treat children with previously incurable acute lymphocytic leukemia (ALL), the most common pediatric cancer. The Karen Jargowsky Fund honors a remarkable woman and has also assisted in the development of the best treatment for pediatric cancers or blood diseases right here in Charlottesville.